{{#rendered}} {{/rendered}}
A man was arrested in Houston, Texas, on allegations he sold and shipped counterfeit cancer drugs worth tens of thousands of dollars to people in the U.S.
Sanjay Kumar, 43, of Bihar, India, was indicted by a federal grand jury on Thursday.
He was arrested on Friday in Houston while he was in the U.S. to negotiate additional deals to expand his illicit business of selling fake oncology pharmaceuticals in the U.S., according to the U.S. Justice Department.
{{#rendered}} {{/rendered}}
SINALOA CARTEL CO-FOUNDER ‘EL MAYO’ TAKEN INTO US CUSTODY
A man was arrested in Houston, Texas, on allegations he sold and shipped counterfeit cancer drugs worth tens of thousands of dollars to people in the U.S. (iStock)
Kumar and his co-conspirators are accused of orchestrating the sale and shipment of counterfeit versions of Keytruda and other oncology pharmaceuticals to unsuspecting people in the U.S.
The DOJ said genuine Keytruda is a cancer immunotherapy that is approved in the U.S. for 19 different indications, including for treatment of lung cancer, head and neck cancer, gastric cancer, cervical cancer, breast cancer, Hodgkin lymphoma and melanoma.
{{#rendered}} {{/rendered}}
MEDICAL EXAMINER IDENTIFIES REMAINS FOUND IN UTAH CANYON AS MISSING TEXAS WOMAN
Sanjay Kumar was arrested on Friday in Houston while he was in the U.S. to negotiate additional deals to expand his illicit business. (iStock)
CLICK HERE TO GET THE FOX NEWS APP
Merck Sharp & Dohme LLC has the exclusive right to manufacture and distribute Keytruda in the U.S., according to the DOJ.
{{#rendered}} {{/rendered}}
Kumar is charged with one count of conspiracy to traffic in counterfeit drugs and four counts of trafficking in counterfeit drugs. If convicted, he could face as many as 20 years in prison on each count.
Source link : https://www.foxnews.com/us/man-from-india-arrested-texas-allegedly-selling-fake-cancer-treatment-drugs-people-us.amp
Author :
Publish date : 2024-07-29 00:09:00
Copyright for syndicated content belongs to the linked Source.
